本页面由Tiger Trade Technology Pte. Ltd.提供服务

Profound Medical Corp.

6.19
-0.1100-1.75%
盘后6.190.00000.00%16:04 EDT
成交量:23.59万
成交额:146.42万
市值:2.25亿
市盈率:-4.40
高:6.44
开:6.19
低:5.94
收:6.30
52周最高:8.95
52周最低:3.76
股本:3,629.30万
流通股本:3,393.81万
量比:0.50
换手率:0.70%
股息:- -
股息率:- -
每股收益(TTM):-1.4081
每股收益(LYR):-1.4081
净资产收益率:-67.12%
总资产收益率:-34.91%
市净率:3.38
市盈率(LYR):-4.40

数据加载中...

2021/03/02

年度报告

40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2021/03/02

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/05

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/15

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/05/20

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/07

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/30

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/10

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/03

年度报告

Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2020/03/03

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/13

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]